During the last session, Thermo Fisher Scientific Inc. (NYSE:TMO)’s traded shares were 0.82 million, with the beta value of the company hitting 0.75. At the end of the trading day, the stock’s price was $568.11, reflecting an intraday gain of 0.47% or $2.64. The 52-week high for the TMO share is $571.67, that puts it down -0.63 from that peak though still a striking 29.4% gain since the share price plummeted to a 52-week low of $401.07. The company’s market capitalization is $225.24B, and the average intraday trading volume over the past 10 days was 0.98 million shares, and the average trade volume was 1.32 million shares over the past three months.
Thermo Fisher Scientific Inc. (TMO) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 1.80. TMO has a Sell rating from 0 analyst(s) out of 24 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 4 suggest Overweight, and 16 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $4.6.
Thermo Fisher Scientific Inc. (NYSE:TMO) trade information
Thermo Fisher Scientific Inc. (TMO) registered a 0.47% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.47% in intraday trading to $568.11 this Friday, 09/03/21, hitting a weekly high. The stock’s 5-day price performance is 3.57%, and it has moved by 4.75% in 30 days. Based on these gigs, the overall price performance for the year is 35.37%. The short interest in Thermo Fisher Scientific Inc. (NYSE:TMO) is 3.0 million shares and it means that shorts have 1.98 day(s) to cover.
The consensus price target of analysts on Wall Street is $579.58, which implies an increase of 1.98% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $535.00 and $626.00 respectively. As a result, TMO is trading at a discount of -10.19% off the target high and 5.83% off the low.
Thermo Fisher Scientific Inc. (TMO) estimates and forecasts
Statistics show that Thermo Fisher Scientific Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Thermo Fisher Scientific Inc. (TMO) shares have gone up 29.16% during the last six months, with a year-to-date growth rate less than the industry average at 12.89% against 16.90. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to shrink -18.30% this quarter and then drop -33.30% in the quarter after that. In the rating firms’ projections, revenue will increase 11.90% compared to the previous financial year.
Revenue for the current quarter is expected to be $8.3 billion as predicted by 17 analyst(s). Meanwhile, a consensus of 17 analyst(s) estimates revenue growth to $8.6 billion by the end of Dec 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $8.52 billion and $10.55 billion respectively. In this case, analysts expect current quarter sales to shrink by -2.60% and then drop by -18.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.50%. While earnings are projected to return 73.80% in 2021, the next five years will return 4.99% per annum.
Thermo Fisher Scientific Inc. is due to release its next quarterly earnings between October 19 and October 25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Thermo Fisher Scientific Inc. is 1.04, with the dividend yield indicating at 0.18 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 0.28%.
Thermo Fisher Scientific Inc. (NYSE:TMO)’s Major holders
Thermo Fisher Scientific Inc. insiders own 0.21% of total outstanding shares while institutional holders control 89.88%, with the float percentage being 90.06%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 2,720 institutions own stock in it. As of Mar 30, 2021, the company held over 30.85 million shares (or 7.85% of all shares), a total value of $14.08 billion in shares.
The next largest institutional holding, with 29.31 million shares, is of Blackrock Inc.’s that is approximately 7.46% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $13.38 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Thermo Fisher Scientific Inc. (TMO) shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. Data provided on Mar 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 11.1 million shares. This amounts to just over 2.82 percent of the company’s overall shares, with a $5.07 billion market value. The same data shows that the other fund manager holds slightly less at 8.06 million, or about 2.05% of the stock, which is worth about $3.68 billion.